7-150952481-C-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000238.4(KCNH2):c.1501G>A(p.Asp501Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D501H) has been classified as Pathogenic.
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.1501G>A | p.Asp501Asn | missense_variant | Exon 6 of 15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 40
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies suggest a damaging effect where p.(D501N) resulted in a 50% reduction in protein trafficking (PMID: 25254353); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25820318, 12402336, 18441445, 19716085, 19352046, 17088455, 26669661, 20486126, 21185501, 29358271, 14998624, 25254353, 25576780, 32383558, 34546463, 30530868, 31737537, 32494459, 36303204, 28794082, 38219013, 36861347, 37324772, 35989994) -
Long QT syndrome Pathogenic:1
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 501 of the KCNH2 protein (p.Asp501Asn). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with long QT syndrome (PMID: 12402336, 14998624, 17088455, 25254353). ClinVar contains an entry for this variant (Variation ID: 67208). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects KCNH2 function (PMID: 25254353). This variant disrupts the p.Asp501 amino acid residue in KCNH2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16414944, 19926013). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Cardiovascular phenotype Pathogenic:1
The p.D501N variant (also known as c.1501G>A), located in coding exon 6 of the KCNH2 gene, results from a G to A substitution at nucleotide position 1501. The aspartic acid at codon 501 is replaced by asparagine, an amino acid with highly similar properties. This variant was reported in multiple individuals with features consistent with long QT syndrome (Jongbloed R et al. Hum Mutat, 2002 Nov;20:382-91; Lupoglazoff JM et al. J Am Coll Cardiol, 2004 Mar;43:826-30; Tan HL et al. Circulation, 2006 Nov;114:2096-103; Nagaoka I et al. Circ J, 2008 May;72:694-9; Kapplinger JD et al. Heart Rhythm, 2009 Sep;6:1297-303; Ogawa K et al. Circ. J., 2009 Nov;73:2169-72; Sadrieh A et al. Nat Commun, 2014 Sep;5:5069; Pundi KN et al. Heart Rhythm, 2015 Apr;12:776-81; Roberts JD et al. Circ Arrhythm Electrophysiol, 2017 Aug;10:[ePub ahead of print]; Kwok SY et al. Hong Kong Med J, 2018 Dec;24:561-570; Westphal DS et al. Mol Genet Genomic Med, 2020 Sep;8:e1300). In multiple assays testing KCNH2 function, this variant showed functionally abnormal results (Sadrieh A et al. Nat Commun, 2014 Sep;5:5069; Thomson KL et al. HGG Adv, 2024 Apr;5:100270). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Congenital long QT syndrome Other:1
This variant has been reported as associated with Long QT syndrome in the following publications (PMID:12402336;PMID:14998624;PMID:18441445;PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at